Charge-dependent targeting: Results in six tumor cell lines

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1347-1351

  Márquez, Marcela ^a   Nilsson, Sten ^a   Lennartsson, Lena ^a   Liu, Zhaoxu ^a,d   Tammela, Teuvo ^b   Raitanen, Mika ^c   Holmberg, Anders R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Cationic dextran; Growth inhibition; Sialic acid

Indexed keywords

ANION; CATION; CATIONIC DEXTRAN; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; LECTIN; SIALIC ACID; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG BINDING; DRUG CYTOTOXICITY; DRUG TARGETING; FLUORESCENCE MICROSCOPY; FLUOROMETRY; HUMAN; HUMAN CELL; MICROTITER PLATE ASSAY; OXIDATION; PRIORITY JOURNAL; REDUCTION; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR GROWTH;

CATIONS; CELL DIVISION; CELL LINE, TUMOR; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; N-ACETYLNEURAMINIC ACID; NEOPLASMS;

EID: 3242738550     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Holmberg AR, Wilchek M, Márquez M, Westlin JE, Du J and Nilsson S: Ion exchange tumor targeting: A new approach. Clin Cancer Res 5: 3056-3058, 1999.
2. Márquez M, Du J, Edgren M, Nilsson S, Lennartsson L, Hiltunen J, Westlin JE, Tammela T, Raitanen M, Laato M, Jönsson G and Holmberg AR: Development of dextran derivatives with cytotoxic effects in human urinary bladder cancer cell lines. Anticancer Res 22: 741-744, 2002.
3. Malykh YN, Schauer R and Shaw L: N-Glycolylneuraminic acid in human tumors. Biochimie 83: 623-634, 2001.
4. Sillanaukee P, Pönnio M and Jääskeläinen IP: Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest 29: 413-425, 1999.
5. Lin S, Kemmne W, Grigull S and Schlag PM: Cell surface α2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res 15: 101-110, 2002.
6. Kawai T, Kato A, Hideyoshi H, Kato S and Naiki M: Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. Cancer Res 51: 1242-1246, 1991.
7. Kökoglu E, Sönmez H, Uslu E and Usly I: Sialic acid in various types of cancer. Cancer Biochem Biophys 13: 57-64, 1992.
8. Khadapkar SV, Sheth NA and Bhide SV: Independence of sialic acid levels in normal and malignant growth. Cancer Res 35: 1520-1523, 1975.
9. Borch RF, Bernstein MD and Dupont Durst H: The cyanohydridoborate anion as a selective reducing agent. J Amer Chem Soc 6: 2897-2904, 1971.
10. Foster R L: Preparation and properties of a soluble trypsin-dextran conjugate. Experentia 31: 772-773, 1975.
11. Riggs HJL: For fluorescent labeling of proteins. Am J Pathol 34: 1081, 1958.
12. Larsson R and Nygren P: A rapid fluorimetric method for semi-automated determination of cytotoxicity and cellular proliferation of human tumor cell lines in microculture. Anticancer Res 9: 1111-1119, 1989.
13. Hakomori S: Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA 6: 10231-10233, 2002.
14. Varki A: Sialic acids as ligands in recognition phenomena. FASEB J 11: 248-255, 1997.
15. Varki A: Diversity in the sialic acids. Glycobiology 2: 25-40, 1992.
16. Inoue S, Lin S-L, Chang T, Wu S-H, Yao C-W, Chu T-Y, Troy II A and Inoue Y: Identification of free deaminated sialic acid in human red blood cells and its elevated expression in fetal cord red blood cells and ovarian cancer cells. J Biol Chem 273: 27199-27204, 1998.
17. Takakura Y and Ktajima M: Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. Physicochemical characteristics and in vivo and in vitro antitumor activities. Int J Pharmaceutics 37: 135-143, 1987.
18. Takakura Y and Takagi A: Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharmaceutic Res 4: 293-300, 1987.